A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Moj, Daniel (VerfasserIn) , Burhenne, Jürgen (VerfasserIn) , Egerer, Gerlinde (VerfasserIn) , Haefeli, Walter E. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 07 October 2017
In: Cancer chemotherapy and pharmacology
Year: 2017, Jahrgang: 80, Heft: 5, Pages: 1013–1026
ISSN:1432-0843
DOI:10.1007/s00280-017-3447-x
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00280-017-3447-x
Volltext
Verfasserangaben:Daniel Moj, Hannah Britz, Jürgen Burhenne, Clinton F. Stewart, Gerlinde Egerer, Walter E. Haefeli, Thorsten Lehr

MARC

LEADER 00000caa a2200000 c 4500
001 1572170344
003 DE-627
005 20230426124248.0
007 cr uuu---uuuuu
008 180419s2017 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00280-017-3447-x  |2 doi 
035 |a (DE-627)1572170344 
035 |a (DE-576)502170344 
035 |a (DE-599)BSZ502170344 
035 |a (OCoLC)1341007398 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Moj, Daniel  |e VerfasserIn  |0 (DE-588)115641606X  |0 (DE-627)1019243570  |0 (DE-576)50217062X  |4 aut 
245 1 2 |a A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification  |c Daniel Moj, Hannah Britz, Jürgen Burhenne, Clinton F. Stewart, Gerlinde Egerer, Walter E. Haefeli, Thorsten Lehr 
264 1 |c 07 October 2017 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.04.2018 
700 1 |a Burhenne, Jürgen  |d 1963-  |e VerfasserIn  |0 (DE-588)1034228889  |0 (DE-627)745126987  |0 (DE-576)381858197  |4 aut 
700 1 |a Egerer, Gerlinde  |e VerfasserIn  |0 (DE-588)105502168X  |0 (DE-627)792516745  |0 (DE-576)167430882  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
773 0 8 |i Enthalten in  |t Cancer chemotherapy and pharmacology  |d Berlin : Springer, 1978  |g 80(2017), 5, Seite 1013–1026  |h Online-Ressource  |w (DE-627)253390435  |w (DE-600)1458488-8  |w (DE-576)072283467  |x 1432-0843  |7 nnas  |a A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification 
773 1 8 |g volume:80  |g year:2017  |g number:5  |g pages:1013–1026  |g extent:14  |a A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification 
856 4 0 |u https://doi.org/10.1007/s00280-017-3447-x  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180419 
993 |a Article 
994 |a 2017 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 105502168X  |a Egerer, Gerlinde  |m 105502168X:Egerer, Gerlinde  |d 910000  |d 910100  |e 910000PE105502168X  |e 910100PE105502168X  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1034228889  |a Burhenne, Jürgen  |m 1034228889:Burhenne, Jürgen  |d 910000  |d 910100  |e 910000PB1034228889  |e 910100PB1034228889  |k 0/910000/  |k 1/910000/910100/  |p 3 
999 |a KXP-PPN1572170344  |e 3006458532 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification","title":"A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1572170344","origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"07 October 2017"}],"id":{"eki":["1572170344"],"doi":["10.1007/s00280-017-3447-x"]},"physDesc":[{"extent":"14 S."}],"note":["Gesehen am 19.04.2018"],"relHost":[{"pubHistory":["1.1978 -"],"language":["eng"],"part":{"issue":"5","extent":"14","pages":"1013–1026","volume":"80","year":"2017","text":"80(2017), 5, Seite 1013–1026"},"title":[{"title_sort":"Cancer chemotherapy and pharmacology","subtitle":"CCP","title":"Cancer chemotherapy and pharmacology"}],"origin":[{"publisher":"Springer","dateIssuedDisp":"1978-","dateIssuedKey":"1978","publisherPlace":"Berlin ; Heidelberg"}],"recId":"253390435","titleAlt":[{"title":"CCP"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 02.12.05","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 38.1996: Supplement"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specificationCancer chemotherapy and pharmacology","id":{"issn":["1432-0843"],"zdb":["1458488-8"],"eki":["253390435"]}}],"name":{"displayForm":["Daniel Moj, Hannah Britz, Jürgen Burhenne, Clinton F. Stewart, Gerlinde Egerer, Walter E. Haefeli, Thorsten Lehr"]},"person":[{"display":"Moj, Daniel","role":"aut","given":"Daniel","family":"Moj"},{"family":"Burhenne","given":"Jürgen","role":"aut","display":"Burhenne, Jürgen"},{"display":"Egerer, Gerlinde","role":"aut","given":"Gerlinde","family":"Egerer"},{"role":"aut","given":"Walter E.","display":"Haefeli, Walter E.","family":"Haefeli"}]} 
SRT |a MOJDANIELBPHYSIOLOGI0720